Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (224)

1

Changes in erythropoiesis-stimulating agent responsiveness after transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis : A prospective multicenter study in Japan

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2023

von Maruyama, Y. | Yokoyama, K. | Higuchi, C. | +9

2

Determination of a Serum 25-Hydroxyvitamin D Reference Ranges in Japanese Adults Using Fully Automated Liquid Chromatography-Tandem Mass Spectrometry

enthalten in: The Journal of nutrition | 2023

von Miyamoto, H. | Kawakami, D. | Hanafusa, N. | +12

3

Iron absorption and phosphate-lowering effects of ferric citrate hydrate are not influenced by gastric acid secretion inhibitors in patients with chronic kidney disease : a retrospective post hoc analysis

enthalten in: International urology and nephrology | 2023

von Ito, K. | Yokoyama, K.

4

Clinical feasibility of transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis : A prospective multicenter study in Japan

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2022

von Maruyama, Y. | Yokoyama, K. | Higuchi, C. | +9

5

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis : Pharmacokinetic and Pharmacodynamic Properties

enthalten in: Clinical pharmacokinetics | 2022

von Kazama, J. | Koiwa, F. | Yokoyama, K. | +4

6

Iron absorption and phosphate-lowering effects of ferric citrate hydrate are not influenced by gastric acid secretion inhibitors in patients with chronic kidney disease: a retrospective post hoc analysis

enthalten in: International urology and nephrology | 2022

von Ito, K. | Yokoyama, K.

7

Iron absorption and phosphate-lowering effects of ferric citrate hydrate are not influenced by gastric acid secretion inhibitors in patients with chronic kidney disease: a retrospective post hoc analysis

enthalten in: International urology and nephrology | 2022

von Ito, K. | Yokoyama, K.

8

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease : a long-term, real-world, observational, post-marketing surveillance study

enthalten in: Clinical and experimental nephrology | 2022

von Yokoyama, K. | Hashimoto, T. | Okuda, Y. | +5

9

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties

enthalten in: Clinical pharmacokinetics | 2022

von Kazama, J. | Koiwa, F. | Yokoyama, K. | +4

10

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties

enthalten in: Clinical pharmacokinetics | 2022

von Kazama, J. | Koiwa, F. | Yokoyama, K. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]